Fig. 2From: Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in ChinaTrends and reductions in DR-TB incidence (A1 and A2), prevalence (B1 and B2), and mortality (C1 and C2) as a result of a theoretical expansion of bedaquiline treatment for DR-TB under 2 treatment success rate scenariosBack to article page